PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21441950-8	2011	Instead, a natural antisense transcript of TP53, WRAP53, was strongly augmented by idarubicin and etoposide, but only less so by the other anthracyclines under study.	Idarubicin	83-93	tumor protein p53	Homo sapiens	43-47	
11699407-5	2001	In cells treated with OL(1) p53 and Idarubicin, truncated p53 message of a predicted 201 base pair length based on RNAase H cleavage of the OL(1) p53-p53 mRNA heteroduplex was detected after 7 hours of incubation.	Idarubicin	36-46	tumor protein p53	Homo sapiens	58-61	
11699407-5	2001	In cells treated with OL(1) p53 and Idarubicin, truncated p53 message of a predicted 201 base pair length based on RNAase H cleavage of the OL(1) p53-p53 mRNA heteroduplex was detected after 7 hours of incubation.	Idarubicin	36-46	tumor protein p53	Homo sapiens	58-61	
11699407-5	2001	In cells treated with OL(1) p53 and Idarubicin, truncated p53 message of a predicted 201 base pair length based on RNAase H cleavage of the OL(1) p53-p53 mRNA heteroduplex was detected after 7 hours of incubation.	Idarubicin	36-46	tumor protein p53	Homo sapiens	58-61	
11699407-9	2001	Therefore, synergistic cytotoxicity of Idarubicin for lymphoma cells treated with an oligonucleotide targeting p53 message was demonstrated at oligonucleotide and Idarubicin concentrations which were minimally toxic to hematopoietic progenitor cells.	Idarubicin	39-49	tumor protein p53	Homo sapiens	111-114	
11699407-9	2001	Therefore, synergistic cytotoxicity of Idarubicin for lymphoma cells treated with an oligonucleotide targeting p53 message was demonstrated at oligonucleotide and Idarubicin concentrations which were minimally toxic to hematopoietic progenitor cells.	Idarubicin	163-173	tumor protein p53	Homo sapiens	111-114	
28751770-4	2018	We show that venetoclax synergizes with cytarabine and idarubicin to increase antileukemic efficacy in a TP53-dependent manner.	Idarubicin	55-65	tumor protein p53	Homo sapiens	105-109